STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected to show a rise in quarterly revenue when it reports results on March 25 (estimated) for the period ending December 31 2024
The Horsham Pennsylvania-based company is expected to report a 44.6% increase in revenue to $8.975 million from $6.21 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for STRATA Skin Sciences Inc is for a loss of 30 cents per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for STRATA Skin Sciences Inc is $11.00, above its last closing price of $2.66.
This summary was machine generated March 21 at 11:23 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)